-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanshan
-
Futian Today
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Budding Writers
-
Fun
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Shopping
-
Business_Markets
-
Restaurants
-
Travel
-
Investment
-
Hotels
-
Yearend Review
-
World
-
Sports
-
Entertainment
-
QINGDAO TODAY
-
In depth
-
Leisure Highlights
-
Markets
-
Business
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> Important news -> 
Laureates’ work stations set up

    2018-03-29  08:53    Shenzhen Daily

TWO work stations named after Nobel laureates were set up at a ceremony for the Stem Cell Technology and Regenerative Medicine Development Seminar in Shenzhen on Tuesday.

The seminar, organized by Shenzhen Zhongxu Cell Regenerative Medicine Co. Ltd., focused on scientific innovation, achievement transformation and industrial development of the stem cell industry in China.

The two work stations set up at the Zhongxu company make up a platform for cooperation between experts from home and abroad in the industrialization of regenerative medicine. Two medical teams headed by two laureates will conduct research on stem cell technologies, tumor medicines, targeted therapies using biological/genetic medicine and technologies for cultivating immune cells.

Randy W. Schekman, a professor of molecular and cell biology at the University of California, Berkeley, won the 2013 Nobel Prize in Physiology or Medicine for his role in revealing the machinery that regulates the transport and secretion of proteins in our cells. Salvador Moncada, director for cancer research at the University of Manchester, won the 1998 Nobel Prize in Medicine.

“Shenzhen has made great achievements in science and technology. I hope I can find cooperation opportunities in the field of stem cell regeneration,” said Randy W. Schekman, in an interview Tuesday after being hired as a top adviser to the Zhongxu company.

Stem cell regeneration research and application has great potential, especially therapies for blood cancer, diabetes, Parkinson’s disease, presbyophrenia, stroke and spine damage, which are difficult to treat with traditional methods, according to Schekman.

Despite many breakthroughs being made in cell extraction and the treatment of such diseases, some difficulties still remain. For example, in insulin-dependent diabetes mellitus (IDDM), the cell that controls diabetes is immunological suppression. However, when it is implanted, the cell can’t play its role, because it is under attack by the patient’s immune system.

“My wife died of Parkinson’s disease last year. Regenerative medicine could be the cure for Parkinson’s disease and presbyophrenia and other genetic diseases,” said Schekman.

(Han Ximin)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn